Pharmaceutical Formulation Development of Peptides and Proteins

This book PDF is perfect for those who love Medical genre, written by Lars Hovgaard and published by CRC Press which was released on 14 November 2012 with total hardcover pages 392. You could read this book directly on your devices with pdf, epub and kindle format, check detail and related Pharmaceutical Formulation Development of Peptides and Proteins books below.

Pharmaceutical Formulation Development of Peptides and Proteins

Author	: Lars Hovgaard
File Size	: 42,6 Mb
Publisher	: CRC Press
Language	: English
Release Date	: 14 November 2012
ISBN	: 9781439853894
Pages	: 392 pages

Get Book

Pharmaceutical Formulation Development of Peptides and Proteins by Lars Hovgaard Book PDF Summary

The rapid advances in recombinant DNA technology and the increasing availability of peptides and proteins with therapeutic potential are a challenge for pharmaceutical scientists who have to formulate these compounds as drug products. Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition discusses the development of therap

Pharmaceutical Formulation Development of Peptides and Proteins by Lars Hovgaard,Sven Frokjaer,Marco van de Weert

Get Book

Pharmaceutical Formulation Development of Peptides and Proteins by Lars Hovgaard,Sven Frokjaer,Marco van de Weert

Pharmaceutical formulation of peptides and proteins has become an important part of modern drug development. Many new drugs are based on peptide or protein recombinant technology going hand in hand with more traditional pharmaceutical formulation. In order to develop products with optimal characters, it is important to give scientists interdisciplinary

Get Book

Protein Formulation and Delivery by Eugene J. McNally,Eugene McNally,Jayne E. Hastedt

This title is intended to assist pharmaceutical scientists in the development of stable protein formulations during the early stages of the product development process, providing a comprehensive review of mechanisms and causes of protein instability in formulation development, coverage of accelerated stability testing methods and relevant analytica

Get Book

Therapeutic Peptides and Proteins by Ajay K. Banga

Upon publication of the first edition of Therapeutic Peptides and Proteins ten years ago there were only 19 biotechology medicines on the market. Currently there are more than 100, with at least 400 more in various stages of development. That alone would be grounds for a new edition. Add to that the fact

Get Book

Stability and Characterization of Protein and Peptide Drugs by Rodney Pearlman,Y. John Wang

This is the first volume to make available specific case histories of therapeutic proteins and peptides that have been marketed or are currently under clinical testing. The editors have selected a wide range of molecules derived from monoclonal antibodies, recombinant DNA, and natural and chemical sources to provide formulation scientists

Get Book

Therapeutic Peptides and Proteins by Ajay K. Banga

There are more than 500 biopharmaceuticals on the market, including more than 200 therapeutic proteins, making biologics the fastest growing sector in the biopharmaceutical market. These products include more than 40 monoclonal antibodies, for indications ranging from treatment or mitigation of various types of cancer to rheumatoid arthritis. The clinical application of these

Get Book

Development and Manufacture of Protein Pharmaceuticals by Steve L. Nail,Michael J. Akers

In this era of biotechnology there have been many books covering the fundamentals of recombinant DNA technology and protein chemistry. However, not many sources are available for the pharmaceutical develop ment scientist and other personnel responsible for the commercialization of the finished dosage forms of these new biopharmaceuticals and other

Get Book

Rational Design of Stable Protein Formulations by John F. Carpenter,Mark C. Manning

Recombinant proteins and polypeptides continue to be the most important class of biotechnology-derived agents in today's pharmaceutical industry. Over the past few years, our fundamental understanding of how proteins degrade and how stabilizing agents work has made it possible to approach formulation of protein pharmaceuticals from a much more rational

Get Book